Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating the long-term safety of the Aveir DR leadless pacemaker

Official title: Aveir Dual-Chamber Leadless Pacemaker Real-World Evidence Post-Approval Study

Run by Abbott Medical Devices · NCT05935007 · Data updated 2026-11-12

This study is testing the long-term safety of the Aveir DR leadless pacemaker in real-world patients to make sure it’s safe for use.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1805 (estimated)
SponsorAbbott Medical Devices
Industry-sponsored
Locations1 site (Sylmar, California)
StatusRecruiting
StartedOctober 31, 2023
Main results expectedDecember 31, 2030
Study endsDecember 31, 2030
Registry record updatedMay 20, 2026
Trial IDNCT05935007 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients who have been implanted with an Aveir DR leadless pacemaker and meet specific Medicare enrollment criteria.

Probably not a fit

Patients who have not received an Aveir DR leadless pacemaker or do not meet the Medicare enrollment criteria may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the long-term safety of the dual-chamber Aveir DR leadless pacemaker using real-world evidence methods. It is a non-randomized, multi-center study that combines various real-world datasets from Abbott and the Center for Medicare Services to evaluate the safety of the Aveir DR device in a large patient population. The findings will fulfill the FDA's Condition of Approval requirements for the Aveir DR device by providing essential long-term safety data.

Why it matters

Potential benefit: If successful, this study could provide critical insights into the long-term safety of the Aveir DR leadless pacemaker, potentially improving patient outcomes.

How similar studies have gone: Other studies utilizing real-world evidence methods have shown promise in evaluating medical devices, suggesting that this approach could yield valuable safety data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Eligibility Criteria:

* Implanted with an Aveir DR leadless pacemaker
* Continuous enrollment in Medicare Part A and Part B for 12 months prior to implant and for -30 days after implant, except in the case of death within the 30-day period
* Ability to link with Medicare fee-for-service data

Where it's running

  • Abbott
    Sylmar, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.